Growth Hormone Did Not Help ALS Patients, Study

A growth hormone that an earlier study had suggested might be effective, showed no benefit compared to placebo in treating patients with amyotrophic lateral sclerosis (ALS) or Lou Gehrig's disease, according to a new study performed by researchers in the United States. The research was conducted by lead author Dr Eric J Sorenson, of the Mayo Clinic in Rochester, Maine, USA, and colleagues, and was published in the 25 November issue of the journal Neurology.
This entry was posted in News from Other Sources. Bookmark the permalink. Both comments and trackbacks are currently closed.